期刊
FUTURE MEDICINAL CHEMISTRY
卷 7, 期 6, 页码 737-752出版社
FUTURE SCI LTD
DOI: 10.4155/FMC.15.31
关键词
-
资金
- German Research Foundation
- Deutsche Forschungsgemeinschaft (DFG) [GR 1549/5-1, GR 1549/5-2, GR 1549/8-1, GR 1549/8-2]
- Bill & Melinda Gates Foundation [OPP1024324]
- Bill and Melinda Gates Foundation [OPP1024324] Funding Source: Bill and Melinda Gates Foundation
For decades, Praziquantel (PZQ) is the drug of choice against one of the most afflicting helminthic diseases worldwide, schistosomiasis. With respect to the fear of upcoming PZQ resistance, efforts are needed to find new chemotherapeutic options. Protein kinases (PKs) are essential molecules in signaling processes and indispensable to life. Aberrant PK functions take distinctive roles in human diseases and represent targets in chemotherapies. In schistosomes, conserved PKs were found to possess similar pivotal roles contributing not only to reproduction processes, but also to the pathology of schistosomiasis, which is closely associated to egg production. Exploiting the similarity of PKs of humans and schistosomes, PK inhibitors designed to treat human diseases may serve as lead compounds for new drugs against schistosomiasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据